Potent ghrelin receptor agonist with cardioprotective signaling at the CD36 scavenger receptor.
Reference facts
- Also known as
- Examorelin
- Category
- Growth Hormone & Ghrelin
- Mechanism of action
- Potent ghrelin receptor agonist with cardioprotective signaling at the CD36 scavenger receptor.
- Targets
- GHS-R1a, CD36
- Indications under research or approved
- Research (GH release, cardiac ischemia models)
- Regulatory status (reference entry)
- Not FDA-approved
- Half-life
- ~70 minutes
- Sequence notes
- Hexapeptide H-His-D-2-MethylTrp-Ala-Trp-D-Phe-Lys-NH2.
- Molecular weight (Da)
- 887
- First reported
- 1992
Primary References
Explore research articles about Hexarelin
This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.